相关实验视频
Updated: Jun 20, 2026

10:55
Digital Microfluidics for Automated Proteomic Processing
Published on: November 6, 2009
12.5K
迈向微流体连续流和生物制药的智能下游加工
Vikas Sharma1, Amirreza Mottafegh1, Jeong-Un Joo1
1Center for Intelligent Microprocess of Pharmaceutical Synthesis, Department of Chemical Engineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea. dpkim@postech.ac.kr.
Lab on a chip
|May 16, 2024
概括
生物制药净化通过微流体技术和智能系统得到了增强. 这些创新提高了个性化药物的效率,成本效益和监管合规性.
科学领域:
- 生物制药制造业 生物制药制造业
- 生物技术是生物技术.
- 工艺工程是过程工程.
背景情况:
- 生物制药是癌症和遗传疾病等疾病的重要治疗方法.
- 高质量的生物制品生产需要复杂,规范的制造工艺,包括广泛的净化.
- 个性化医疗需要新的,高效的净化技术.
研究的目的:
- 审查小规模生物制药下游加工中连续,综合和智能方法的意义,挑战和前景.
- 突出微流体技术和智能系统在提升净化过程中的作用.
- 探索这些进步如何支持个性化的精密纳米药物.
主要方法:
- 专注于微流体技术,用于精确,紧的分离和快速净化模块.
- 智能生物制造系统与用于自动化和先进控制的微型设备的集成.
- 强调下游加工中的连续,综合和智能方法.
主要成果:
- 微流体技术可以实现精确,紧和连续的净化.
- 智能系统提供自动化,实时监控和改进的数据管理.
- 集成提高了流程效率,稳定性和监管遵守 (GMP).
结论:
- 采用微流体和智能系统显著提高生物制药净化.
- 这些技术提高了效率,成本效益和监管合规性.
- 这一整合将塑造个性化疗法的生物制药生产的未来.
相关概念视频
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Downstream Processing
Downstream processing begins once fermentation is complete and involves a series of steps to recover and purify products such as acids, vitamins, antibiotics, or proteins.Cell HarvestingFor example, for intracellular protein-based products, the first step is harvesting the cells. This is typically achieved using centrifugation or filtration to separate the cells from the liquid phase.Cell Disruption for Intracellular ProductsIf the target product is intracellular, the harvested cells must be...

